Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Two cases of concomitant acquired aplastic anemia and systemic mastocytosis.

Golardi N, Sramek JE, Myers JB, Saffer H, George TI, Czuchlewski DR.

Hum Pathol. 2014 Feb;45(2):417-20. doi: 10.1016/j.humpath.2013.08.002. Epub 2013 Oct 31.

PMID:
24182560
2.

Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria.

Jordan JH, Schernthaner GH, Fritsche-Polanz R, Sperr WR, Födinger M, Chott A, Geissler K, Lechner K, Horny HP, Valent P.

Leuk Lymphoma. 2002 Mar;43(3):575-82.

PMID:
12002761
3.

Mastocytosis: state of the art.

Horny HP, Sotlar K, Valent P.

Pathobiology. 2007;74(2):121-32. Review.

PMID:
17587883
4.

Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.

Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP.

J Mol Diagn. 2008 Jan;10(1):58-66. doi: 10.2353/jmoldx.2008.070061. Epub 2007 Dec 28. Erratum in: J Mol Diagn. 2009 May;10(3):276.

5.

Systemic mastocytosis.

Ozdemir D, Dagdelen S, Erbas T.

Am J Med Sci. 2011 Nov;342(5):409-15. doi: 10.1097/MAJ.0b013e3182121131. Review.

PMID:
21629042
6.

The faces of mast cell disease: bone marrow infiltrates in 3 patients with systemic mastocytosis.

Martinez AE, Medina AM, Hyde JA, Krill-Jackson E, Blaustein A, Schwartz M, Cabello-Inchausti B.

Ann Diagn Pathol. 2005 Apr;9(2):81-5.

PMID:
15806514
7.

[Mastocytosis and eosinophilic leukemia: diagnostics and classification].

Sotlar K, Valent P, Horny HP.

Pathologe. 2012 Nov;33(6):539-52. doi: 10.1007/s00292-012-1654-0. German.

PMID:
23085697
8.

Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.

Horny HP, Sotlar K, Valent P.

Pathobiology. 2010;77(4):169-80. doi: 10.1159/000305552. Epub 2010 Jul 7. Review.

PMID:
20616612
9.

Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow.

Johnson MR, Verstovsek S, Jorgensen JL, Manshouri T, Luthra R, Jones DM, Bueso-Ramos CE, Medeiros LJ, Huh YO.

Mod Pathol. 2009 Jan;22(1):50-7. doi: 10.1038/modpathol.2008.141. Epub 2008 Sep 19.

10.

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM.

Leuk Res. 2001 Jul;25(7):603-25. Review.

PMID:
11377686
11.
12.

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.

Morgado JM, Perbellini O, Johnson RC, Teodósio C, Matito A, Álvarez-Twose I, Bonadonna P, Zamò A, Jara-Acevedo M, Mayado A, Garcia-Montero A, Mollejo M, George TI, Zanotti R, Orfao A, Escribano L, Sánchez-Muñoz L.

Histopathology. 2013 Dec;63(6):780-7. doi: 10.1111/his.12221. Epub 2013 Sep 20.

PMID:
24111625
13.

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, Caballero T, Rosado A, Sánchez Matas I, Teodósio C, Jara-Acevedo M, Mollejo M, García-Montero A, Orfao A, Escribano L.

J Allergy Clin Immunol. 2010 Jun;125(6):1269-1278.e2. doi: 10.1016/j.jaci.2010.02.019.

PMID:
20434205
14.

An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).

Horny HP, Sotlar K, Stellmacher F, Valent P, Grabbe J.

J Clin Pathol. 2006 Mar;59(3):264-8.

15.

Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia.

Zeng W, Nakao S, Takamatsu H, Yachie A, Takami A, Kondo Y, Sugimori N, Yamazaki H, Miura Y, Shiobara S, Matsuda T.

Blood. 1999 May 1;93(9):3008-16.

16.
17.

Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.

Gasljevic G, Grcar-Kuzmanov B, Grosel A, Sever M, Gazic B, Kloboves-Prevodnik V.

Diagn Pathol. 2015 Mar 14;10:5. doi: 10.1186/s13000-015-0235-y.

18.

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.

Sotlar K, Cerny-Reiterer S, Petat-Dutter K, Hessel H, Berezowska S, Müllauer L, Valent P, Horny HP.

Mod Pathol. 2011 Apr;24(4):585-95. doi: 10.1038/modpathol.2010.224. Epub 2010 Dec 24.

19.

The stromal composition of mast cell aggregates in systemic mastocytosis.

Chiu A, Nanaji NM, Czader M, Gheorghe G, Knowles DM, Chadburn A, Orazi A.

Mod Pathol. 2009 Jul;22(7):857-65. doi: 10.1038/modpathol.2009.53. Epub 2009 Apr 24.

20.

High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.

Gülen T, Hägglund H, Dahlén B, Nilsson G.

Clin Exp Allergy. 2014 Jan;44(1):121-9. doi: 10.1111/cea.12225.

PMID:
24164252

Supplemental Content

Support Center